| 000 | 01016 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517105916.0 | ||
| 264 | 0 | _c20180808 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2015.65.7130 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRastogi, Sameer | |
| 245 | 0 | 0 |
_aTrabectedin in Soft Tissue Sarcoma: Have We Hit the Bull's-eye? _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c10 2016 |
||
| 300 |
_a3582-3583 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aDioxoles |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aSarcoma |
| 650 | 0 | 4 | _aTetrahydroisoquinolines |
| 650 | 0 | 4 | _aTrabectedin |
| 700 | 1 | _aBakhshi, Sameer | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 34 _gno. 29 _gp. 3582-3583 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2015.65.7130 _zAvailable from publisher's website |
| 999 |
_c26265892 _d26265892 |
||